Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients

Context: Critically ill patients has a large number of pathophysiological changes product of commitment and organ systems. Therefore, knowledge of the pharmacological properties of antimicrobials is essential to choose the best treatment. In order to optimize the response of antibiotic therapy and t...

Full description

Bibliographic Details
Main Authors: Jorge S. Amador, Juan P. Carrasco, Álvaro A. Morales, Claudia P. Cortes
Format: Article
Language:English
Published: Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) 2017-04-01
Series:Journal of Pharmacy & Pharmacognosy Research
Subjects:
Online Access:http://jppres.com/jppres/pdf/vol5/jppres16.157_5.2.88.pdf
id doaj-72005f45118c48e485a7fc799d981402
record_format Article
spelling doaj-72005f45118c48e485a7fc799d9814022020-11-25T00:06:28ZengAcademic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)Journal of Pharmacy & Pharmacognosy Research0719-42502017-04-01528895Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patientsJorge S. Amador0Juan P. Carrasco1Álvaro A. Morales2Claudia P. Cortes3Unidad de Paciente Crítico Adulto. Hospital Clínico San Borja Arriarán, Santiago, Chile.Unidad de Paciente Crítico Adulto. Hospital Clínico San Borja Arriarán, Santiago, Chile.Unidad de Paciente Crítico Adulto. Hospital Clínico San Borja Arriarán, Santiago, Chile.Facultad de Medicina. Universidad de Chile, Santiago, Chile.Context: Critically ill patients has a large number of pathophysiological changes product of commitment and organ systems. Therefore, knowledge of the pharmacological properties of antimicrobials is essential to choose the best treatment. In order to optimize the response of antibiotic therapy and these drugs, new strategies have been proposed dosage, the most used drug application of the model, called: Pharmacokinetics/Pharmacodynamics (PK/PD). In the case of β-lactam antibiotics, the PK/PD model is known as time-dependent on the Minimum Inhibitory Concentration (Time > MIC). For optimal concentrations in β-lactam antibiotics, prolonged or continuous infusions, thus exposing the drug on the pathogen is achieved in a longer optimal concentrations through are used. Aims: To evaluate the therapeutic response of β-lactam antibiotics in critically ill patients with prolonged infusions by applying the model PK/ PD. Methods: Prospective observational study (concurrent cohort), taking as a control non-concurrent historic cohort, conducted for a period of seven months in the intensive care unit of the Hospital Clínico San Borja Arriarán (HCSBA), Santiago, Chile. Results: It was found a significant difference in number of days of hospitalization in ICU for the group bolus versus infusion group (12.5 ± 5.4 vs. 18 ± 9.7 days, IC: 1.5-9.5; p = 0.009). Conclusions: This study suggests that there would be a therapeutic advantage in the use of prolonged infusion in ICU stay duration.http://jppres.com/jppres/pdf/vol5/jppres16.157_5.2.88.pdfcritically ill patientsβ-lactam antibioticsprolonged infusion
collection DOAJ
language English
format Article
sources DOAJ
author Jorge S. Amador
Juan P. Carrasco
Álvaro A. Morales
Claudia P. Cortes
spellingShingle Jorge S. Amador
Juan P. Carrasco
Álvaro A. Morales
Claudia P. Cortes
Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients
Journal of Pharmacy & Pharmacognosy Research
critically ill patients
β-lactam antibiotics
prolonged infusion
author_facet Jorge S. Amador
Juan P. Carrasco
Álvaro A. Morales
Claudia P. Cortes
author_sort Jorge S. Amador
title Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients
title_short Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients
title_full Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients
title_fullStr Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients
title_full_unstemmed Therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients
title_sort therapeutic evaluation of prolonged infusions of β-lactam antibiotics in the treatment and management of critically ill patients
publisher Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
series Journal of Pharmacy & Pharmacognosy Research
issn 0719-4250
publishDate 2017-04-01
description Context: Critically ill patients has a large number of pathophysiological changes product of commitment and organ systems. Therefore, knowledge of the pharmacological properties of antimicrobials is essential to choose the best treatment. In order to optimize the response of antibiotic therapy and these drugs, new strategies have been proposed dosage, the most used drug application of the model, called: Pharmacokinetics/Pharmacodynamics (PK/PD). In the case of β-lactam antibiotics, the PK/PD model is known as time-dependent on the Minimum Inhibitory Concentration (Time > MIC). For optimal concentrations in β-lactam antibiotics, prolonged or continuous infusions, thus exposing the drug on the pathogen is achieved in a longer optimal concentrations through are used. Aims: To evaluate the therapeutic response of β-lactam antibiotics in critically ill patients with prolonged infusions by applying the model PK/ PD. Methods: Prospective observational study (concurrent cohort), taking as a control non-concurrent historic cohort, conducted for a period of seven months in the intensive care unit of the Hospital Clínico San Borja Arriarán (HCSBA), Santiago, Chile. Results: It was found a significant difference in number of days of hospitalization in ICU for the group bolus versus infusion group (12.5 ± 5.4 vs. 18 ± 9.7 days, IC: 1.5-9.5; p = 0.009). Conclusions: This study suggests that there would be a therapeutic advantage in the use of prolonged infusion in ICU stay duration.
topic critically ill patients
β-lactam antibiotics
prolonged infusion
url http://jppres.com/jppres/pdf/vol5/jppres16.157_5.2.88.pdf
work_keys_str_mv AT jorgesamador therapeuticevaluationofprolongedinfusionsofblactamantibioticsinthetreatmentandmanagementofcriticallyillpatients
AT juanpcarrasco therapeuticevaluationofprolongedinfusionsofblactamantibioticsinthetreatmentandmanagementofcriticallyillpatients
AT alvaroamorales therapeuticevaluationofprolongedinfusionsofblactamantibioticsinthetreatmentandmanagementofcriticallyillpatients
AT claudiapcortes therapeuticevaluationofprolongedinfusionsofblactamantibioticsinthetreatmentandmanagementofcriticallyillpatients
_version_ 1725421892894982144